Efficacy and Safety of Low-dose Tirofiban in Aged Patients with ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
BACKGROUND: Studies have shown that percutaneous coronary intervention combined with tirofiban therapy could improve the blood supply of heart and reduce cardiac infarction.This study aimed to study the efficacy and safety of low-dose tirofiban in the treatment of elderly patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention.
L.Ren W.G.Wang Q.Wang J.Zhang X.Y.Tang J.S.Feng H.M.Yang Q.S.Wang
The First Hospital of Qinhuangdao,Qinhuangdao, China
国内会议
苏州
英文
335-335
2015-09-11(万方平台首次上网日期,不代表论文的发表时间)